Disseminating clinical study results to trial participants in Ethiopia: insights and lessons learned
International regulatory authorities and funders require that research be disseminated promptly and appropriately to all involved stakeholders. However, following completion of clinical trials participants often either do not receive any feedback or materials provided are not appropriate for the con...
Auteurs principaux: | Degaga, TS, Weston, S, Tego, TT, Abate, DT, Aseffa, A, Wayessa, A, Price, RN, Hailu, A, Thriemer, K |
---|---|
Format: | Journal article |
Langue: | English |
Publié: |
BioMed Central
2020
|
Documents similaires
-
Disseminating clinical study results to trial participants in Ethiopia: insights and lessons learned
par: Tamiru S. Degaga, et autres
Publié: (2020-06-01) -
Reducing the risk of Plasmodium vivax after falciparum infections in co-endemic areas—a randomized controlled trial (PRIMA)
par: Thriemer, K, et autres
Publié: (2022) -
Primaquine radical cure in patients with Plasmodium falciparum malaria in areas co-endemic for P falciparum and Plasmodium vivax (PRIMA): a multicentre, open-label, superiority randomised controlled trial
par: Thriemer, K, et autres
Publié: (2022) -
Natural Enemies of the fall armyworm (Spodoptera frugiperda Smith) and comparing Neem aqueous extracts with its larvae, Gurage zone, central Ethiopia
par: Abera Hailu Degaga, et autres
Publié: (2024-06-01) -
Chloroquine efficacy for Plasmodium vivax malaria treatment in southern Ethiopia
par: Getachew, S, et autres
Publié: (2015)